Welcome to ConnecticutLifeScience.com
ConnecticutLifeScience.com is part of a specialized network of state- and province-based biotechnology, medical device,
and life science sites that includes more than 4,500 biotechnology, medical device, pharmaceutical companies,
non-profit research institutions, universities and supporting service sector companies across the U.S. and Canada.
This network addresses the growing informational and service needs of companies, patients, educators and others in
their respective states while providing clients the opportunity to cost effectively
advertise their job openings, events, facility availability and other services at the state level,
regionally or nationwide. We welcome your comments, suggestions and requests for informational content and supporting
services.
 More...
Destination Connecticut
Are you considering a move to Connecticut? Relocating your business to
Connecticut? Starting a company? Or just interested in Connecticut?
This section will answer many of your questions regarding the life science industry in Connecticut, the province's
economy, tax structure and cost of living, education, transportation, climate, recreational opportunities, history,
industry resources, and more.
More...
|
|
|
Local News...
Free News Release Posting & Archiving Service
- Amrubicin receives FDA Fast Track Designation for the treatment of small cell lung cancer Celgene announced that Amrubicin has been granted Fast Track product designation by the U.S. Food and Drug Administration (FDA) for the treatment of small cell lung cancer after first-line chemotherapy.
Celgene Corporation September 04, 2008
- FDA assigns priority review to GTC Biotherapeutics' ATryn(R) The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics' Biologic License Application, or BLA, for ATryn(R). Under Priority Review, the FDA's target date for action on the BLA is February 7, 2009.
GTC Biotherapeutics, Inc. September 04, 2008
- USPTO Office Action in the Reexamination of U.S. Patent No. 6,545,040 Forest Laboratories announced that an Office Action in the Reexamination of U.S. Patent No. 6,545,040 ("the '040 patent") was received from the U.S. Patent and Trademark Office ("USPTO") by Janssen Pharmaceutica N.V., the patent holder of the '040 patent.
Forest Laboratories, Inc. September 04, 2008
- Applied Biosystems teams With leaders in CT and NJ to drive stem cell research Scientists conducting stem cell research are convening at symposia in mid-September in Connecticut and New Jersey to share best practices, drive standardization to advance science, and enable greater collaboration.
Applied Biosystems September 04, 2008
- Forest Laboratories announced Phase III studies of aclidinium bromide Forest Laboratories and Laboratorios Almirall announced results from two global Phase III studies of aclidinium bromide, a novel long-acting inhaled anticholinergic for the treatment of patients with chronic obstructive pulmonary disease.
Forest Laboratories, Inc. September 03, 2008
More... | Submit News Release | National News
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
Free Event Posting Service
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Connecticut's BioHistory
Why is there a biotechnology industry in Connecticut? Will the industry continue
to grow in Connecticut? What do other states have? Each state has a unique story
that explains why a given industry has developed in a specific region and not in others.
Through Connecticut BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industries in the state of Connecticut.
More...
BioEvolution Posters
More...
Your Guide to Reporting Problems to FDA
Consumers play an important public health role by reporting to the Food and
Drug Administration (FDA) any adverse events (unexpected side effects) after
using a medical product, or other problems with any products that the agency
regulates.
Timely reporting allows the agency to take prompt action. There are a
number of ways you can report problems to the agency, depending on the type of
problem and product.
More...
BioFact
(1892) - Rudploh Diesel, a german engineer creates the diesel engine, an internal combustion engine originally designed to operate with vegetable oil (not gas).
It's a Small World
|
| |
Cancer Cell
| |
Science Quote
"Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world. Science is the highest personification of the nation because that nation will remain the first which carries the furthest the works of thought and intelligence."
| - |
Louis Pasteur, French microbiologist and chemist
|
|
(1822-1895)
|
|
